Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Melanoma × Melphalan × Clear all

Status

Completed 12 Withdrawn 3 Not yet recruiting 2 No longer available 1 Enrolling by invitation 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1 Dermatologic 1

Conditions

Uveal Melanoma 1 Multiple Myeloma 1 Melanoma 1 Liver Neoplasms 1

Interventions

trametinib 3 dabrafenib 3 talimogene laherparepvec 2 pembrolizumab 2 Nivolumab 2 Ipilimumab 2 pegilodecakin 1 omaveloxolone 1 efineptakin alfa 1 aldesleukin 1 Melphalan 1 Cyclophosphamide 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01728051 2013-10-23

Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver

Delcath Systems Inc.

No longer available

DermatologicGastrointestinal

Uveal Melanoma, Liver Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡